Evidence map›Paper›PMID 26151683›Full record

ArticleAnalytical biochemistry2015

Label-free DNA sequencing using Millikan detection.

Roger Dettloff, Danielle Leiske, Andrea Chow, Javier Farinas

Abstract read
In one paragraph

Article in Analytical biochemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 91% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Roger DettloffCaerus Molecular Diagnostics, Mountain View, CA 94043, USA.
Danielle LeiskeCaerus Molecular Diagnostics, Mountain View, CA 94043, USA.
Andrea ChowPromega BioSystems, Sunnyvale, CA 94085, USA.
Javier FarinasCaerus Molecular Diagnostics, Mountain View, CA 94043, USA. Electronic address: javier_farinas@caerusmdx.com.
Caerus Molecular Diagnostics (United States) · USPromega (United States) · US

Funding

Millikan Sequencing by Label-Free Detection of Nucleotide IncorporationR43HG005865 · NHGRI · CAERUS MOLECULAR DIAGNOSTICS, INC. · PI FARINAS, JAVIER · 2010 to 2012
$607k
NHGRI NIH HHS 5R43HG005865NHGRI NIH HHS R43 HG005865
6 · The paper itself

Abstract

A label-free method for DNA sequencing based on the principle of the Millikan oil drop experiment was developed. This sequencing-by-synthesis approach sensed increases in bead charge as nucleotides were added by a polymerase to DNA templates attached to beads. The balance between an electrical force, which was dependent on the number of nucleotide charges on a bead, and opposing hydrodynamic drag and restoring tether forces resulted in a bead velocity that was a function of the number of nucleotides attached to the bead. The velocity of beads tethered via a polymer to a microfluidic channel and subjected to an oscillating electric field was measured using dark-field microscopy and used to determine how many nucleotides were incorporated during each sequencing-by-synthesis cycle. Increases in bead velocity of approximately 1% were reliably detected during DNA polymerization, allowing for sequencing of short DNA templates. The method could lead to a low-cost, high-throughput sequencing platform that could enable routine sequencing in medical applications.

Indexed as

High-Throughput Nucleotide SequencingMicrofluidic Analytical TechniquesOilsParticle SizeSequence Analysis, DNASurface PropertiesOilsDNA sequencingTethered beads

Identifiers

PMID26151683
PMCPMC4560655
OpenAlexW2195643876

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.